产品详情 |
CD40 ligand is a 261 amino acid type II transmembrane glycoprotein belonging to the TNF family and can be cleaved into two chains: the CD40 ligand membrane form and CD40 ligand soluble form. It is primarily expressed on activated CD4+ T lymphocytes, and also found in other types of cells, like NK cells, mast cells, basophils and eosinophils. In total CD40 ligand has three binding partners: CD40, α5β1 integrin and αIIbβ3. It mediates a range of activities on B cells including induction of activation-associated surface antigen, entry into cell cycle, isotype switching and Ig secretion and memory generation. CD40- CD40L interaction also plays important roles in monocyte activation and dendritic cell maturation. The soluble form of CD40L is an 18kDa protein comprising the entire TNF homologous region of CD40L and is generated in vivo by an intracellular proteolytic processing of the full length CD40L. Recombinant Human soluble CD40 ligand is a 16.3kDa protein containing 149 amino acid residues comprising the receptor binding TNF-like domain of CD40L.
Product Information
Product Name
|
Recombinant Human soluble CD40 Ligand
(rHusCD40L)
|
Synonyms
|
soluble CD40 Ligand, TNFSF5, TRAP, CD154, Gp39, T-BAM
|
Source
|
Expressed in E. coli.
|
Molecular weight
|
Approximately 16.3kDa, a single non-glycosylated polypeptide chain containing 149 amino acids.
|
Accession
|
P29965 Met113-Leu261
|
AA Sequence
|
MQKGDQNPQIAAHVISEASSKTTSVLQWAEKGYYTMSNNLVTLENGKQLTVKRQGLYYIYAQVTFCSNREASSQAPFIASLWLKSPGRFERILLRAANTHSSAKPCGQQSIHLGGVFELQPGASVFVNVTDPSQVSHGTGFTSFGLLKL
|
Purity
|
>97% by SDS-PAGE or HPLC
|
Formulation
|
Lyophilized from a 0.2mm filtered solution in in 20mM PB, 150mM NaCl, pH 7.0.
|
Biological activity
|
Fully biologically active when compared to standard. The ED50 as determined by the dose-dependent stimulation of IL-8 production by human PBMC is less than 5-10 ng/ml.
|
Endotoxin level
|
Less than 1 EU/mg of rHusCD40L as determined by LAL method
|
Reconstitution
|
Before use this product, please read the direction below carefully.
1、 This vial must be briefly centrifuged prior to opening to bring the contents to the bottom.
2、 Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/ml.
Stock solutions should be apportioned into working aliquots and stored at ≤-20℃. Further dilutions should be made in appropriate buffered solutions.
|
Storage/ Stability
|
White lyophilized powder. For long term storage, the product should be stored ≤-20℃. Please avoid repeated freeze-thaw cycles after reconstitution.
12 months from date of receipt, -20 to -70℃ as supplied.
1 month, 2 to 8℃ under sterile conditions after reconstitution.
3 months, -20 to -70℃ under sterile conditions after reconstitution.
|
THIS PRODUCT IS FOR RESEARCH, LABORATORY AND EVALUATION PURPOSE ONLY.
|
|